OncoPep Garners $6,900,000 Series B Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ce9be8d9-0a69-403e-be71-08092725dd72 - Date
8/28/2014 - Company Name
OncoPep - Mailing Address
520 Boston Street North Andover, MA 01845 USA - Company Description
OncoPep, Inc. was founded in 2010 to commercialize a novel approach to developing targeted immunotherapeutics against cancer. The Company’s proprietary core technology was developed in the laboratory of Dr. Kenneth Anderson, M.D., a world leader in cancer treatment, at the Dana Farber Cancer Institute. - Website
http://www.oncopep.com - Transaction Type
Venture Equity - Transaction Amount
$6,900,000 - Transaction Round
Series B - Proceeds Purposes
Proceeds raised will support the clinical development of PVX-410, currently being studied in patients with smoldering multiple myeloma (SMM), an asymptomatic stage of MM. - M&A Terms
- Venture Investor
- Venture Investor
